Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

1.531,40 -4,90 (-0,32%) Al cierre: 03:29PM IST

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
https://www.sunpharma.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 41.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Dilip Shantilal Shanghvi	MD & Executive Director	54,53M	N/A	1955
Mr. Kalyanasundaram Subramanian	Director of Corporate Development	65,3M	N/A	1954
Mr. C. S. Muralidharan	Chief Financial Officer	38,89M	N/A	1963
Mr. Davinder Singh	Executive Vice-President of Global Operations	N/A	N/A	N/A
Mr. Dheeraj Prasad Sinha BE	EVP & Chief Information Officer	N/A	N/A	1971
Mr. Nimish Desai	Head of Investor Relations	N/A	N/A	N/A
Mr. Anoop Deshpande	Company Secretary & Compliance Officer	N/A	N/A	N/A
Mr. Suresh Kumar Rai	Chief Human Resources Officer	N/A	N/A	N/A
Mr. Kirti Wardhaman Ganorkar	Chief Executive Officer of India Business	N/A	N/A	1967
Mr. Aalok Dilip Shanghvi	Executive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time Director	N/A	N/A	1984

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en INR.

Descripción

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Gobierno corporativo

El ISS Governance QualityScore de Sun Pharmaceutical Industries Limited, a día 1 de mayo de 2024, es 2. Las puntuaciones base son Auditoría: 5; Tablero: 2; Derechos de los accionistas: 1; Compensación: 5.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.